Effects of an Avocado Based meDiterranean Diet on Serum Lipids for Secondary Prevention After Ischemic StrokE Trial. Study Protocol.
NCT03524742 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200
Last updated 2023-08-15
Summary
Recent global burden of disease analysis of DALYs, showed that dietary risk have the highest DALYs in ischemic stroke among behavioral risk factors. The MediDiet is associated with a decreased risk of total mortality as well as stroke incidence and mortality. Although not part of the classical Mediterranean diet they are another nutrient-dense source of MUFA, rich in vitamins, minerals, fiber, phytosterols and polyphenols extensively consumed in the Americas. Avocado-substituted diets significantly decrease cholesterol levels in diabetic and obese patients. Secondary stroke prevention studies with diet as an intervention are lacking and there is little information of what patients eat before or after an ischemic stroke. Lowering Low Density Cholesterol (LDL-C) levels decreases stroke recurrence. The aim is to determine the effect of a Mediterranean style diet based on Avocados on lipid profile particularly LDL-C in patients who have had an ischemic stroke and are at high recurrence risk.Methodology: Academic, open-label, blinded outcome assessment (PROBE design), clinical trial. Participants will be patients with an acute ischemic stroke admitted to Clínica Alemana de Santiago, who fulfills the eligibility criteria. Eligible patients will be randomly assigned to either diet intervention in a 1:1 ratio. The interventions will be: A) Avocado based Mediterranean diet with intake of ½ portion of a Hass avocado per day and B) Standard recommendation of low fat-high complex carbohydrate diet recommended by the National Cholesterol Education Program and the American Heart Association. The main efficacy outcome will be the level of plasma LDL-C level at 3 months of the dietary intervention. Secondary outcomes will be changes in: Levels of serum lipid profile, serum inflammation markers, glycemic control, anthropomorphic measures, stroke recurrence, cardiovascular events, adverse events, compliance. A sample size of 100 patients per group (200 in total) was estimated to provide 80% power and 5% level of significance with 10% loss and 5% crossover to detect the same difference in LDL-C after 3 months of intervention in patients with acute stroke. The investigators hypothesize that an Avocado based Mediterranean diet will significantly reduce levels of LDL-cholesterol at 3 months in patients who have suffered a recent acute ischemic stroke compared to the standard diet.
Conditions
- Stroke, Acute
- Stroke, Ischemic
Interventions
- OTHER
-
Avocado-Mediterranean Diet
Mediterranean diet including 1/2 portion of Hass avocado per day, considering a minimum 35% of calories as fat (22% MUFA fat, 6% PUFA fat, and ±10% saturated fat), 15% proteins, and a maximum of 50% carbohydrates.
- OTHER
-
Control-Group Diet
A low fat-high complex carbohydrate diet, during 3 months.
Sponsors & Collaborators
-
Comisión Nacional de Investigación Científica y Tecnológica
collaborator OTHER_GOV -
Clinica Alemana de Santiago
lead OTHER
Principal Investigators
-
Veronica Olavarria, MD · Clinica Alemana de Santiago
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 45 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-08-16
- Primary Completion
- 2023-01-19
- Completion
- 2023-01-19
Countries
- Chile
Study Locations
More Related Trials
-
Citrulline Efficacy to Improve Carbohydrate Metabolism Abnormalities in the Patient Treated With High Doses of Statin
NCT03596684 ·Status: COMPLETED ·Phase: NA
-
Treat Stroke to Target
NCT01252875 ·Status: COMPLETED ·Phase: NA
-
COAST Study - Cholesterol Optimization After Stroke
NCT07256171 ·Status: NOT_YET_RECRUITING
-
Assessment of the Effects of Long-term Lipid-lowering Therapy in Patients With Primary STEMI or NSTEMI
NCT04347434 ·Status: RECRUITING ·Phase: PHASE4
-
Effect of Atorvastatin on the Frequency of Ventilator-associated Pneumonia in Patients With Ischemic Stroke
NCT01550419 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Could Early Atorvastatin Offer Anti Inflammatory Effects Upon Brain in Traumatic Head Injury?
NCT04718155 ·Status: COMPLETED ·Phase: NA
-
Intracranial Hemorrhage Risk of Intensive Statin in Acute Ischemic Stroke With Cerebral Microbleeds
NCT05589454 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
An Observational Study of Statin Treatment Induced HDL Changes
NCT01551784 ·Status: COMPLETED
-
The Effects of Allicor on Patients After Revascularization Treatment During a Year
NCT05813171 ·Status: UNKNOWN ·Phase: PHASE4
-
Atorvastatin Pre-Treatment Influences the Risk of Percutaneous Coronary Intervention Study
NCT00469326 ·Status: COMPLETED ·Phase: PHASE3
-
Assessment of the Effects of Atorvastatin Therapy on Myocardial Deformation Characteristics, in Patients With STEMI
NCT02590653 ·Status: COMPLETED ·Phase: PHASE4
-
The Effect of InTensive Statin in Ischemic Stroke With inTracranial Atherosclerotic Plaques
NCT03753555 ·Status: RECRUITING ·Phase: PHASE4
-
Atorvastatin Pretreatment in Cerebrovascular Events (APICES) After Flow Diverter Implantation
NCT06308952 ·Status: RECRUITING ·Phase: PHASE4
-
The Association of Statins on Cardiorespiratory Fitness and Exercise Adaptation
NCT04986241 ·Status: COMPLETED
-
Merck Carotid Atherosclerosis Trial (MK-0000-111)(COMPLETED)
NCT00804843 ·Status: COMPLETED ·Phase: PHASE2
-
Atorvastatin Treatment to Attenuate the Progression of Cardiovascular Disease in Hemodialysis Patients
NCT00481364 ·Status: COMPLETED ·Phase: PHASE3
-
Aggressive Medical Treatment Evaluation for Asymptomatic Carotid Artery Stenosis
NCT00805311 ·Status: TERMINATED ·Phase: PHASE4
-
Statin and Dual Antiplatelet Therapy to Prevent Early Neurological Deterioration in Branch Atheromatous Disease
NCT04824911 ·Status: COMPLETED ·Phase: PHASE2
-
Anti-inflammatory Effect of Atorvastatin in Atherosclerotic Plaques Assessed by FDG-PET Imaging
NCT00920101 ·Status: UNKNOWN ·Phase: PHASE4
-
High Dose Atorvastatin for Preventing Periprocedural Ischemic Brain Damage During Carotid Artery Stenting
NCT03079115 ·Status: UNKNOWN ·Phase: PHASE4
-
Early Therapeutic Effects of Statins and Fibrates on Unstable Atherosclerotic Plaques
NCT00243672 ·Status: WITHDRAWN ·Phase: PHASE4
-
Effect of Statins on Oxidative Stress and Endothelial Progenitor Cells
NCT00166036 ·Status: COMPLETED ·Phase: PHASE2
-
Atorvastatin for Preventing Occlusion and Restenosis After Intracranial Artery Stenting
NCT01255852 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of the Effect of Long-term Lipid-lowering Therapy in STEMI Patients With Coronavirus Infection COVID-19
NCT04900155 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Short Term Statin Treatment and Endothelial Dysfunction Due to Ischemia and Reperfusion Injury
NCT00987974 ·Status: COMPLETED ·Phase: PHASE4